Bank of America’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-220,523
| Closed | -$2.87M | – | 8506 |
|
|
2022
Q2 | $2.87M | Sell |
220,523
-846
| -0.4% | -$10.9K | ﹤0.01% | 3964 |
|
|
2022
Q1 | $3.44M | Buy |
221,369
+70,423
| +47% | +$1.19M | ﹤0.01% | 4017 |
|
|
2021
Q4 | $3.22M | Sell |
150,946
-188
| -0.1% | -$4.78K | ﹤0.01% | 4085 |
|
|
2021
Q3 | $4.45M | Buy |
151,134
+150,736
| +37,873% | +$4.54M | ﹤0.01% | 3670 |
|
|
2021
Q2 | $12K | Sell |
398
-296
| -43% | -$9.24K | ﹤0.01% | 7269 |
|
|
2021
Q1 | $22K | Buy |
694
+287
| +71% | +$9.66K | ﹤0.01% | 6868 |
|
|
2020
Q4 | $15K | Buy |
407
+96
| +31% | +$3.61K | ﹤0.01% | 6655 |
|
|
2020
Q3 | $12K | Sell |
311
-37
| -11% | -$1.34K | ﹤0.01% | 6420 |
|
|
2020
Q2 | $12K | Sell |
348
-115
| -25% | -$4.09K | ﹤0.01% | 6403 |
|
|
2020
Q1 | $16K | Sell |
463
-54
| -10% | -$1.88K | ﹤0.01% | 6247 |
|
|
2019
Q4 | $17K | Buy |
517
+136
| +36% | +$4.07K | ﹤0.01% | 6539 |
|
|
2019
Q3 | $10K | Sell |
381
-29
| -7% | -$655 | ﹤0.01% | 6728 |
|
|
2019
Q2 | $9K | Buy |
+410
| New | +$8.28K | ﹤0.01% | 6754 |
|
|
2019
Q1 | – | Sell |
-148
| Closed | -$2K | – | 7527 |
|
|
2018
Q4 | $2K | Buy |
148
+98
| +196% | +$1.29K | ﹤0.01% | 6926 |
|
|
2018
Q3 | $1K | Sell |
50
-34
| -40% | -$513 | ﹤0.01% | 7180 |
|
|
2018
Q2 | $1K | Sell |
84
-791
| -90% | -$12K | ﹤0.01% | 7013 |
|
|
2018
Q1 | $14K | Buy |
+875
| New | +$13.6K | ﹤0.01% | 6506 |
|
Other funds holding ZEAL
Bank of America's ZEAL Position: Q3 2022 in Review
Bank of America sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2022, closing a stake of 220,523 shares — an estimated $2.87M sold.
Bank of America first reported a position in ZEAL in Q1 2018 and held it in 17 quarters. The position peaked at $4.45M in Q3 2021. 1 fund tracked by Wall St. Rank holds ZEAL as of Q3 2022.
- Bank of America reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2022 after selling out during the quarter.
- Bank of America sold 220,523 Zealand Pharma A/S American Depositary Shares shares in Q3 2022, an estimated $2.87M.
- Bank of America first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2018 and held it in 17 quarters.
- Bank of America's Zealand Pharma A/S American Depositary Shares position peaked at $4.45M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2022.
Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.